These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19964723)

  • 1. Visualization and segmentation of liver tumors using dynamic contrast MRI.
    Raj A; Juluru K
    Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():6985-9. PubMed ID: 19964723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hybrid hemodynamic knowledge-powered and feature reconstruction-guided scheme for breast cancer segmentation based on DCE-MRI.
    Lv T; Wu Y; Wang Y; Liu Y; Li L; Deng C; Pan X
    Med Image Anal; 2022 Nov; 82():102572. PubMed ID: 36055051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T(1) mapping.
    Braren R; Curcic J; Remmele S; Altomonte J; Ebert O; Rummeny EJ; Steingoetter A
    Invest Radiol; 2011 Oct; 46(10):624-31. PubMed ID: 21577121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of hemodynamic imaging findings of hypervascular hepatocellular carcinoma: comparison between dynamic contrast-enhanced magnetic resonance imaging using radial volumetric imaging breath-hold examination with k-space-weighted image contrast reconstruction and dynamic computed tomography during hepatic arteriography.
    Kurozumi M; Fujinaga Y; Kitou Y; Yamada A; Ohya A; Adachi Y; Tsukahara Y; Nickel MD; Maruyama K; Uehara T; Miyagawa SI; Kadoya M
    Jpn J Radiol; 2018 Apr; 36(4):295-302. PubMed ID: 29327116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative free-breathing dynamic contrast-enhanced MRI in hepatocellular carcinoma using gadoxetic acid: correlations with Ki67 proliferation status, histological grades, and microvascular density.
    Chen J; Chen C; Xia C; Huang Z; Zuo P; Stemmer A; Song B
    Abdom Radiol (NY); 2018 Jun; 43(6):1393-1403. PubMed ID: 28939963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR imaging in cirrhosis and hepatocellular carcinoma.
    Barr DC; Hussain HK
    Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):315-35. PubMed ID: 25086932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
    Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
    Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of gadoxetic acid-enhanced magnetic resonance imaging and contrast-enhanced computed tomography with histopathological examinations for the identification of hepatocellular carcinoma: a multicenter phase III study.
    Tsurusaki M; Sofue K; Isoda H; Okada M; Kitajima K; Murakami T
    J Gastroenterol; 2016 Jan; 51(1):71-9. PubMed ID: 26130441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiscale model of liver DCE-MRI towards a better understanding of tumor complexity.
    Mescam M; Kretowski M; Bezy-Wendling J
    IEEE Trans Med Imaging; 2010 Mar; 29(3):699-707. PubMed ID: 19758856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCC-to-liver contrast on arterial-dominant phase images of EOB-enhanced MRI: comparison with dynamic CT.
    Kanata N; Yoshikawa T; Ohno Y; Kanda T; Uchida K; Izaki K; Fukumoto T; Ku Y; Itoh T; Kitajima K; Takahashi S; Sugimura K
    Magn Reson Imaging; 2013 Jan; 31(1):17-22. PubMed ID: 22898685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal compartment segmentation in DCE-MRI images.
    Yang X; Le Minh H; Tim Cheng KT; Sung KH; Liu W
    Med Image Anal; 2016 Aug; 32():269-80. PubMed ID: 27236222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced magnetic resonance imaging of tumors: preclinical validation of parametric images.
    Egeland TA; Simonsen TG; Gaustad JV; Gulliksrud K; Ellingsen C; Rofstad EK
    Radiat Res; 2009 Sep; 172(3):339-47. PubMed ID: 19708783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive segmentation, registration, and cancer detection scheme on 3 Tesla in vivo prostate DCE-MRI.
    Viswanath S; Bloch BN; Genega E; Rofsky N; Lenkinski R; Chappelow J; Toth R; Madabhushi A
    Med Image Comput Comput Assist Interv; 2008; 11(Pt 1):662-9. PubMed ID: 18979803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of dynamic subtraction MRI in detection of hepatocellular carcinoma.
    Seçil M; Obuz F; Altay C; Gencel O; Iğci E; Sağol O; Dicle O
    Diagn Interv Radiol; 2008 Dec; 14(4):200-4. PubMed ID: 19061165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cirrhosis and pre-neoplastic lesions.
    Grazioli L; Olivetti L; Orlando E
    Abdom Imaging; 2012 Apr; 37(2):188-214. PubMed ID: 22297506
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlative study of angiogenesis and dynamic contrast-enhanced magnetic resonance imaging features of hepatocellular carcinoma.
    Wang B; Gao ZQ; Yan X
    Acta Radiol; 2005 Jul; 46(4):353-8. PubMed ID: 16134309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravoxel incoherent motion diffusion-weighted imaging of hepatocellular carcinoma: Is there a correlation with flow and perfusion metrics obtained with dynamic contrast-enhanced MRI?
    Hectors SJ; Wagner M; Besa C; Bane O; Dyvorne HA; Fiel MI; Zhu H; Donovan M; Taouli B
    J Magn Reson Imaging; 2016 Oct; 44(4):856-64. PubMed ID: 26919327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal acquisition delay for dynamic contrast-enhanced MRI of hypervascular hepatocellular carcinoma.
    Goshima S; Kanematsu M; Kondo H; Shiratori Y; Onozuka M; Moriyama N; Bae KT
    AJR Am J Roentgenol; 2009 Mar; 192(3):686-92. PubMed ID: 19234264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.